Posterior tibial nerve stimulation and anticholinergic drug solifenacin in patients with overactive bladder
Phase 3
Recruiting
- Conditions
- Overactive bladder.Overactive bladderN32.81
- Registration Number
- IRCT20190618043934N25
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 118
Inclusion Criteria
Having informed consent to enter the study
Passing urine more than 8 times in 24 hours
At least 6 months have passed since the onset of symptoms
Creating an emergency to urinate, which is accompanied by urgency urinary incontinence
Exclusion Criteria
Refusal to continue the plan
pregnancy
having a history of surgery to treat urinary incontinence
treatment with anticholinergic drugs
having a urinary tract infection
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of Life. Timepoint: At the beginning of the study and 3 months after the start of the intervention. Method of measurement: Using a questionnaire to assess the quality of life of patients with lower urinary tract disorders.;Overactive bladder symptoms. Timepoint: At the beginning of the study and 3 months after the start of the intervention. Method of measurement: Using the overactive bladder symptoms evaluation questionnaire.
- Secondary Outcome Measures
Name Time Method